Literature DB >> 8648664

Genomic quasispecies associated with the initiation of infection and disease in ponies experimentally infected with equine infectious anemia virus.

D L Lichtenstein1, C J Issel, R C Montelaro.   

Abstract

Equine infectious anemia virus (EIAV) provides a uniquely dynamic system in which to study the mechanism and role of genomic variation in lentiviral persistence and pathogenesis. We have used a Shetland pony model of infection to investigate the association of specific long terminal repeat (LTR) and env gene genomic sequences with the initiation of infection and the onset of disease. We analyzed viral RNA isolated from a pathogenic stock of virus (EIAV PV) and from plasma taken during the first disease episode from two ponies infected with EIAV PV. Overall sequence variation within gp90 was low in EIAV PV and only slightly higher in plasma virus samples isolated from ponies during the first disease episode. However, a high proportion of mutations were localized to the principal neutralizing domain in EIAV PV and to the principal neutralizing domain and the gp90 hypervariable region in the two pony-derived samples. The rate of fixation of mutations was analyzed and determined to be approximately 4 x 10(-2) mutations per site per year. Sequence diversity within the U3 region of the LTR was extremely low, which suggested that the previously reported hypervariability of this region may be a consequence of selection for replication of EIAV in different host cells. The predominant EIAV PV env and LTR sequences were used to construct chimeric viruses so that the contribution of these sequences to viral pathogenicity could be examined. The chimeras replicated in cultured equine monocytes to the same extent as the parental nonpathogenic virus and did not cause disease in Shetland ponies by 120 days postinfection, suggesting that the EIAV genomic determinants of pathogenesis are complex.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8648664      PMCID: PMC190205     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

1.  Selection of genetic variants of simian immunodeficiency virus in persistently infected rhesus monkeys.

Authors:  D P Burns; R C Desrosiers
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

2.  In vitro isolation of a neutralization escape mutant of equine infectious anemia virus (EIAV).

Authors:  P M Rwambo; C J Issel; K A Hussain; R C Montelaro
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

3.  Identification of a hypervariable region in the long terminal repeat of equine infectious anemia virus.

Authors:  S Carpenter; S Alexandersen; M J Long; S Perryman; B Chesebro
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

4.  Lentivirus genomic organization: the complete nucleotide sequence of the env gene region of equine infectious anemia virus.

Authors:  K Rushlow; K Olsen; G Stiegler; S L Payne; R C Montelaro; C J Issel
Journal:  Virology       Date:  1986-12       Impact factor: 3.616

5.  Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations.

Authors:  A Meyerhans; R Cheynier; J Albert; M Seth; S Kwok; J Sninsky; L Morfeldt-Månson; B Asjö; S Wain-Hobson
Journal:  Cell       Date:  1989-09-08       Impact factor: 41.582

6.  Antigenic variation and lentivirus persistence: variations in envelope gene sequences during EIAV infection resemble changes reported for sequential isolates of HIV.

Authors:  S L Payne; F D Fang; C P Liu; B R Dhruva; P Rwambo; C J Issel; R C Montelaro
Journal:  Virology       Date:  1987-12       Impact factor: 3.616

7.  Course and extent of variation of equine infectious anemia virus during parallel persistent infections.

Authors:  S L Payne; O Salinovich; S M Nauman; C J Issel; R C Montelaro
Journal:  J Virol       Date:  1987-04       Impact factor: 5.103

8.  Selection, recombination, and G----A hypermutation of human immunodeficiency virus type 1 genomes.

Authors:  J P Vartanian; A Meyerhans; B Asjö; S Wain-Hobson
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

9.  Equine infectious anemia virus (EIAV) humoral responses of recipient ponies and antigenic variation during persistent infection.

Authors:  P M Rwambo; C J Issel; W V Adams; K A Hussain; M Miller; R C Montelaro
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

10.  Localization of conserved and variable antigenic domains of equine infectious anemia virus envelope glycoproteins using recombinant env-encoded protein fragments produced in Escherichia coli.

Authors:  S L Payne; K Rushlow; B R Dhruva; C J Issel; R C Montelaro
Journal:  Virology       Date:  1989-10       Impact factor: 3.616

View more
  18 in total

1.  Envelope variation as a primary determinant of lentiviral vaccine efficacy.

Authors:  Jodi K Craigo; Baoshan Zhang; Shannon Barnes; Tara L Tagmyer; Sheila J Cook; Charles J Issel; Ronald C Montelaro
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-10       Impact factor: 11.205

2.  In vivo dynamics of equine infectious anemia viruses emerging during febrile episodes: insertions/duplications at the principal neutralizing domain.

Authors:  Y H Zheng; H Sentsui; T Nakaya; Y Kono; K Ikuta
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

3.  Novel and dynamic evolution of equine infectious anemia virus genomic quasispecies associated with sequential disease cycles in an experimentally infected pony.

Authors:  C Leroux; C J Issel; R C Montelaro
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

4.  Equine infectious anemia virus genomic evolution in progressor and nonprogressor ponies.

Authors:  C Leroux; J K Craigo; C J Issel; R C Montelaro
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

5.  Unique evolution characteristics of the envelope protein of EIAV(LN₄₀), a virulent strain of equine infectious anemia virus.

Authors:  Xuefeng Wang; Shuai Wang; Yuezhi Lin; Chenggang Jiang; Jian Ma; Liping Zhao; Xiaoling Lv; Fenglong Wang; Rongxian Shen; Jianhua Zhou
Journal:  Virus Genes       Date:  2011-01-08       Impact factor: 2.332

6.  Amino acid mutations in the env gp90 protein that modify N-linked glycosylation of the Chinese EIAV vaccine strain enhance resistance to neutralizing antibodies.

Authors:  Xiue Han; Ping Zhang; Wei Yu; Wenhua Xiang; Xiaodong Li
Journal:  Virus Genes       Date:  2016-08-29       Impact factor: 2.332

7.  Horses naturally infected with EIAV harbor 2 distinct SU populations but are monophyletic with respect to IN.

Authors:  Diana T Cervantes; Judith M Ball; John Edwards; Susan Payne
Journal:  Virus Genes       Date:  2016-01-06       Impact factor: 2.332

8.  Characterization of an equine macrophage cell line: application to studies of EIAV infection.

Authors:  Isabel Fidalgo-Carvalho; Jodi K Craigo; Shannon Barnes; Carolina Costa-Ramos; Ronald C Montelaro
Journal:  Vet Microbiol       Date:  2008-11-01       Impact factor: 3.293

9.  Influence of long terminal repeat and env on the virulence phenotype of equine infectious anemia virus.

Authors:  Susan L Payne; Xiao-fang Pei; Bin Jia; Angela Fagerness; Frederick J Fuller
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

10.  An EIAV field isolate reveals much higher levels of subtype variability than currently reported for the equine lentivirus family.

Authors:  Jodi K Craigo; Shannon Barnes; Baoshan Zhang; Sheila J Cook; Laryssa Howe; Charles J Issel; Ronald C Montelaro
Journal:  Retrovirology       Date:  2009-10-20       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.